All research
MOTS-c 2026-06-27 EuropePMC

Precision Cardiogenomics Offers Path to Stratify Sudden Cardiac Death Risk in Athletes

Precision Cardiogenomics in Athletes

Background

Sudden cardiac death (SCD) remains the leading medical cause of death in athletes under 35 years, often being the first manifestation of underlying cardiac disease in seemingly healthy individuals. While SCD occurs in approximately 1.3 per 100,000 in the general population, this risk escalates to 1 per 66,000 to 88,000 in young athletic populations, with even higher incidences in elite male soccer and basketball players. Current understanding of the pathophysiology underlying SCD in athletes is incomplete, limiting opportunities for tailored therapies and accurate risk stratification. Intense physical activity, with its rapid shifts in autonomic balance and persistent catecholaminergic drive, creates a vulnerable electrophysiological window in genetically susceptible myocardium, highlighting the urgent need for precision approaches.

Study Design

This review synthesizes existing literature on precision cardiogenomics in athletes, aiming to elucidate the molecular pathways underlying disease penetrance and identify opportunities for improved risk stratification. The authors conducted a comprehensive analysis, drawing insights from 154 studies encompassing 987 molecular associations related to cardiac health and athletic performance. Evidence was rigorously categorized into Grades 1 through 4 based on methodological rigor, omics integration, reproducibility, and translational relevance to human physiology and disease models. The focus was on identifying genetic predispositions and molecular mechanisms that contribute to SCD risk during or immediately after intense physical activity, particularly those involving autonomic nervous system shifts and myocardial excitability in susceptible individuals.

Results

The synthesis of current knowledge highlights that while clinical syndromes associated with SCD are increasingly recognized, the molecular pathways driving disease penetrance remain poorly understood. Exertion acts as a critical trigger, with rapid shifts in parasympathetic nervous system withdrawal followed by sympathetic nervous system activation increasing myocardial excitability and lowering the threshold for ventricular arrhythmias. The transition from peak exertion to early recovery is characterized by persistent catecholaminergic drive, dynamic shifts in repolarization reserve, and transient calcium handling instability, creating a highly vulnerable electrophysiological state. The review identified 59 molecular associations (Grades 1-2) with strong methodological rigor and translational relevance, underscoring the potential of precision cardiogenomics to unravel these complex interactions.

The risk of sudden cardiac death is magnified in young athletic populations, estimated at 1 per 66,000 to 88,000, with even higher incidences in specific populations such as elite male soccer and basketball players.

This suggests that genetic predispositions, combined with the physiological stress of exercise, are key determinants of SCD risk, necessitating a more granular, personalized approach to screening and prevention.

Key Findings

  • Sudden cardiac death (SCD) is the leading medical cause of death in athletes under 35 years.
  • SCD risk is 1 per 66,000 to 88,000 in young athletes, significantly higher than the general population.
  • Intense exercise triggers SCD by increasing myocardial excitability and electrical instability in susceptible individuals.
  • The transition from peak exertion to recovery creates a vulnerable electrophysiological window due to catecholaminergic drive and calcium handling instability.
  • Precision cardiogenomics holds promise for improved risk stratification by identifying underlying genetic predispositions.

Why It Matters

This comprehensive review underscores the critical need for integrating precision cardiogenomics into athlete screening protocols to enhance SCD risk stratification. For clinicians and sports medicine practitioners, boldidentifying athletes with specific genetic predispositions could enable personalized training recommendations and targeted interventions, moving beyond current generalized screening methods. The insights into autonomic nervous system dynamics and myocardial excitability during exertion suggest that future protocols might involve genetic testing alongside advanced physiological monitoring to pinpoint individuals at highest risk. While a usable clinical protocol is still some distance away, this work lays the groundwork for developing more precise diagnostic tools and preventative strategies, potentially saving lives by preventing the first, often fatal, manifestation of underlying cardiac disease. It highlights that understanding the molecular underpinnings of SCD is paramount for developing truly tailored therapies.


sudden-cardiac-death athletes cardiogenomics arrhythmia genetics risk-stratification
Source: europepmc:epmc_PMC13299431 · Ingested 2026-06-27 · Digest: gemini-2.5-flash